Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE: 600222)
Health Care · Pharmaceuticals · CN
CN¥7.78
-1.39% today · +16.5% 1Y
Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE: 600222) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $625.37M and employs 2,084 people.
Over the last twelve months the share price has gained 16.5%, trading between 6.24 and 9.44.
Tweenvest scores Henan Taloph Pharmaceutical Stock Co.,Ltd across four factors: quality 63/100, value 28/100, growth 30/100, dividend 8/100. Its strongest factor is quality.
600222 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $625.37M
- Revenue (TTM)
- $255.18M
- P/E
- 81.60
- EPS
- 0.10
- Dividend yield
- 0.18%
- Beta (5Y)
- 0.72
- 52-week high
- CN¥9.44
- 52-week low
- CN¥6.24
- Avg volume (3M)
- —
- Shares outstanding
- 538.40M
- Employees
- 2,084
- Next earnings
- —
About Henan Taloph Pharmaceutical Stock Co.,Ltd
Operating from Zhengzhou, China, Henan Taloph Pharmaceutical Stock Co., Ltd. specializes in the research, development, production, and sale of a wide array of Chinese and Western medicines across the nation. The company's product line encompasses various forms, such as oral liquids, tablets, capsules, and injectable fluids. Notable products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, and pazufloxacin mesylate sodium chloride injections, alongside a selection of other infusion products. Taloph Pharmaceutical serves a diverse client base, including hospitals, pharmacies, and direct consumers. It was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd.
- ISIN
- CNE0000010L8
- Founded
- 1998
- Listed since
- Nov 5, 1999
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Newland Pharmaceutical Co., Ltd.SZSE: 301277 | $629.84M | CN¥10.76 | +2.77% |
| TTY Biopharm Company LimitedTPEX: 4105 | $629.11M | NT$80.90 | +2.53% |
| Senores Pharmaceuticals LimitedNSEI: SENORES | $628.13M | Rs1,320.00 | -2.19% |
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $625.65M | CN¥20.91 | -0.90% |
| Shanghai New World Co., LtdSHSE: 600628 | $623.88M | CN¥6.46 | +1.57% |
| Sun Pharma Advanced Research Company LimitedNSEI: SPARC | $622.35M | Rs185.60 | -1.14% |
| Jinling Pharmaceutical Company LimitedSZSE: 000919 | $619.32M | CN¥6.67 | +2.62% |
| Zhuhai Rundu Pharmaceutical Co., Ltd.SZSE: 002923 | $612.48M | CN¥12.25 | +11.06% |
Figures last refreshed Oct 11, 2026.